Medication info
Calidimax Soft Capsule (Alfacalcidol)

Calidimax Soft Capsule (Alfacalcidol)

OTC medicationSoft capsule경구
Ingredient · strength
Alfacalcidol›0.5μg / 1 capsule
Manufacturer / importer
맥널티제약(주)
Appearance
Yellow oval soft capsule containing a colorless or transparent oily liquid
Packaging
30 capsules/bottle, 100 capsules/bottle
Approval status
Active

MFDS item code 202503096 · Notified 2025.11.27

Summary

Main use
Improvement of symptoms of vitamin D metabolism disorders (hypocalcemia, bone lesions, etc.) and osteoporosis
Who takes it
Adults · Children
Adult dose
For chronic kidney disease and osteoporosis: Administer 0.5 to 1 µg once daily as alfacalcidol. For hypoparathyroidism and other diseases due to vitamin D metabolism disorders: Administer 1 to 4 µg once daily as this medication.
Child dose
For osteoporosis: Administer 0.01 to 0.03 µg per kg of body weight once daily as alfacalcidol. For other diseases: Administer 0.05 to 0.1 µg per kg of body weight once daily as this medication.

Ingredients

Manufacturer
맥널티제약(주)

Efficacy & effects

Improvement of symptoms of vitamin D metabolism disorders (hypocalcemia, bone lesions, etc.) and osteoporosis

  • Hypocalcemia
  • tetany
  • bone pain
  • bone lesions
  • chronic kidney disease
  • hypoparathyroidism
  • vitamin D resistant rickets
  • osteomalacia
  • osteoporosis
View approved original text

This medication is used to improve symptoms of hypocalcemia, muscle cramps (tetany), bone pain, and bone lesions due to vitamin D metabolism disorders such as chronic kidney disease, hypoparathyroidism, vitamin D resistant rickets, and osteomalacia. It is also effective for bone diseases such as osteoporosis. Therefore, this drug is useful for enhancing bone health and alleviating associated symptoms.

How to take

Adult dose

For chronic kidney disease and osteoporosis: Administer 0.5 to 1 µg once daily as alfacalcidol. For hypoparathyroidism and other diseases due to vitamin D metabolism disorders: Administer 1 to 4 µg once daily as this medication.

Child dose

For osteoporosis: Administer 0.01 to 0.03 µg per kg of body weight once daily as alfacalcidol. For other diseases: Administer 0.05 to 0.1 µg per kg of body weight once daily as this medication.

Precautions

This drug should not be taken by patients with abnormally high levels of calcium, phosphorus, and magnesium in the blood or those with alkalosis. It should also be avoided in cases of vitamin D toxicity symptoms or allergic reactions to any of the ingredients in this medication. During the administration of this drug, it is important not to take magnesium-containing preparations, vitamin D-related medications, calcium-containing preparations, and certain diuretics together. Women who are breastfeeding should avoid this medication if possible as its safety has not been established, and if it is absolutely necessary to take it, it is advisable to stop breastfeeding. Women who are pregnant or may become pregnant should consult a doctor before taking this medication as it may pose risks to the fetus. Children, elderly individuals, patients taking certain medications, and those with a history of kidney stones should consult a professional before taking this drug. If abnormal symptoms or side effects occur during administration, it is important to stop taking it immediately and consult a healthcare professional. In case of overdose, emergency measures such as inducing vomiting or gastric lavage may be necessary, so caution is required. This drug should be stored in a cool, dry place away from direct sunlight and kept out of reach of children.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash accompanied by high fever, blisters, skin peeling, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headaches, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urine changes

Mild side effects

  • Loss of appetite
  • nausea
  • vomiting
  • diarrhea
  • constipation
  • stomach pain
  • discomfort in the stomach area
  • abdominal bloating
  • indigestion
  • thirst
Show 24 more
  • oral discomfort
  • polydipsia
  • pancreatitis
  • metallic taste
  • muscle cramps in the legs
  • headache
  • heaviness in the head
  • insomnia
  • anxiety
  • weakness
  • lethargy
  • dizziness
  • numbness
  • drowsiness
  • heartburn
  • shoulder stiffness
  • presbycusis
  • tinnitus
  • decreased memory and cognitive ability
  • acute psychosis
  • consciousness disturbance
  • back pain
  • mild increase in blood pressure
  • palpitations

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a container that can block light and air, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage can maintain the drug's effectiveness for a long time and prevent deterioration.

Appearance and packaging

Appearance

Yellow oval soft capsule containing a colorless or transparent oily liquid

Package unit

30 capsules/bottle, 100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.